Evidence map›Paper›PMID 31665381›Full record

ArticleThe Journal of nutrition2020

Oral 25-Hydroxycholecalciferol Acts as an Agonist in the Duodenum of Mice and as Modeled in Cultured Human HT-29 and Caco2 Cells.

Carmen J Reynolds, Nicholas J Koszewski, Ronald L Horst, Donald C Beitz, Jesse P Goff

Abstract read
In one paragraph

Article in The Journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Analysis of vitamin DJournal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2024
    Article
  2. Dietary 25-hydroxyvitamin DJournal of feline medicine and surgery · 2022
    Article
  3. Article
  4. Role of glucuronidated 25-hydroxyvitamin D on colon gene expression in mice.American journal of physiology. Gastrointestinal and liver physiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carmen J ReynoldsDepartment of Animal Science, Iowa State University, Ames, IA, XSUSA.
Nicholas J KoszewskiDepartment of Biomedical Sciences, Iowa State University, Ames, IA, USA.
Ronald L HorstGlycoMyr, Inc., Ames, IA, USA.
Donald C BeitzDepartment of Animal Science, Iowa State University, Ames, IA, XSUSA.
Jesse P GoffDepartment of Biomedical Sciences, Iowa State University, Ames, IA, USA.

Funding

Using vitamin D glucuronide pro-drugs to prevent/treat colon cancerR15CA173628 · NCI · IOWA STATE UNIVERSITY · PI GOFF, JESSE PAUL · 2013 to 2016
$886k
NCI NIH HHS R15 CA173628
6 · The paper itself

Abstract

background25-Hydroxycholecalciferol [25(OH)D] is the predominant circulating metabolite of vitamin D and serves as the precursor for 1α,25-dihydroxycholecalciferol [1,25(OH)2D], the hormonally active form. The presence of 1α-hydroxylase (1α-OHase) in the intestine suggests that 1,25(OH)2D can be produced from 25(OH)D, but the effects of oral 25(OH)D on the intestine have not been determined.

objectivesWe investigated the acute intestinal response to orally consumed 25(OH)D in mice by assessing mRNA induction of cytochrome p450 family 24 subfamily A member 1 (Cyp24), a vitamin D-dependent gene. The mechanism of action then was determined through in vitro analyses with Caco2 and HT-29 cells.

methodsAdult male C57BL6 mice were given a single oral dose of 40, 80, 200, or 400 ng 25(OH)D (n = 4 per dose) or vehicle (n = 3), and then killed 4 h later to evaluate the duodenal expression of Cyp24 mRNA by qPCR and RNA in situ hybridization. The 25(OH)D-mediated response was also evaluated with Caco2 and HT-29 cells by inhibition assay and dose-response analysis. A cytochrome p450 family 27 subfamily B member 1 (CYP27B1) knockdown of HT-29 was created to compare the dose-response parameters with wild-type HT-29 cells.

resultsOral 25(OH)D induced expression of Cyp24 mRNA in the duodenum of mice with 80 ng 25(OH)D by 3.3 ± 0.8 ΔΔCt compared with controls (P < 0.05). In vitro, both Caco2 and HT-29 cells responded to 25(OH)D treatment with 200-fold and 175-fold greater effective concentration at 50% maximal response than 1,25(OH)2D, yet inhibition of 1α-OHase and knockdown of CYP27B1 had no effect on the responses.

conclusionsIn mice, orally consumed 25(OH)D elicits a vitamin D-mediated response in the duodenum. In vitro assessments suggest that the response from 25(OH)D does not require activation by 1α-OHase and that 25(OH)D within the intestinal lumen acts as a vitamin D receptor agonist.

Indexed as

25-Hydroxyvitamin D3 1-alpha-HydroxylaseAdministration, OralAnimalsCaco-2 CellsCalcifediolCytochrome P450 Family 24Dose-Response Relationship, DrugDuodenumGene Knockdown TechniquesHT29 CellsHumansMaleMiceMice, Inbred C57BL25-Hydroxyvitamin D3 1-alpha-HydroxylaseCalcifediolCytochrome P450 Family 2425-hydroxyvitamin DCYP27B1intestineVDRvitamin D

Identifiers

PMID31665381
PMCPMC7443726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.